Results 201 to 210 of about 736,711 (345)

Transforming long-term post-acute care for the aging population through home infusion therapy in China: assurance for quality and safety of care delivery (Part 2). [PDF]

open access: yesFront Public Health
Zuo W   +17 more
europepmc   +1 more source

Implementation of a 24-Hour Pharmacy Service with Prospective Medication Review in the Emergency Department

open access: yesHospital Pharmacy, 2015
B. Sin   +5 more
semanticscholar   +1 more source

Harm reduction and pharmacy practice: a scoping review of services for people who use drugs provided by pharmacy staff. [PDF]

open access: yesBMJ Open
Navarrete J   +7 more
europepmc   +1 more source

NHS Alcohol consumption survey 2009 [PDF]

open access: yes, 2009
Brackstone, J.   +2 more
core  

Consistency and clarity of pharmacogenomic guidance in UK medicine patient information leaflets: A cross‐sectional analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Pharmacogenomic (PGx) information has the potential to support the safe and effective use of medicines, yet there is uncertainty about how this information can be best communicated to patients. Summaries of product characteristics (SmPCs) and patient information leaflets (PILs) for all UK‐approved medicines with strong evidence supporting a PGx ...
Parth Narlawar   +5 more
wiley   +1 more source

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari   +2 more
wiley   +1 more source

Learning with Patient Campaigners About a German Drug Scandal

open access: yesBerichte zur Wissenschaftsgeschichte, EarlyView.
The West German drug Duogynon was internationally marketed as a “hormone pregnancy test” (HPT) between the 1950s and 1980s. In the late 1960s it came under suspicion for inducing miscarriage, spina bifida, and a spectrum of birth defects similar to those caused by the sedative thalidomide.
Jesse Olszynko‐Gryn   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy